Cardiac risk after mediastinal irradiation for Hodgkin's disease

Radiotherapy and Oncology

Volumn 46, Issue 1, 1998, Pages 51-62

  Glanzmann, Christoph ^a   Kaufmann, Philipp ^a   Jenni, Rolf ^a   Hess, Othmar M ^a   Huguenin, Pia ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cardiac risk; Heart irradiation; Hodgkin's disease; Mediastinal irradiation; Normal tissue tolerance; Radiation tolerance

Indexed keywords

DOXORUBICIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CHILD; CLINICAL PROTOCOL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HEART DISEASES; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0031950650     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00125-4     Document Type: Article

References (51)

1. Anderson, K.M., Wilson, P.W.F., Odell, P.M. and Kannel, W.B. An updated coronary risk profile. A statement for health professionals. Circulation 83: 356-362, 1991.
2. Applefeld, M.M. and Wiernik, P.H. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am. J. Cardiol. 51: 1679-1681, 1983.
3. Bodenmann, A., Ackermann-Liebrich, U. and Keller, U. Fleischkonsum und Serumcholesterinkonzentration. Deutsche Med. Wochenschrift. 116: 1089-1094, 1991.
4. Boivin, J.F., Hutchinson, G.B., Lubin, J.H. and Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69: 1241-1247, 1992.
5. Bonadonna, G. Modern treatment of malignant lymphomas: a multidisciplinary approach? Ann. Oncol. 5 (Suppl. 2): 5-16, 1994.
6. Breslow, N.E. and Day, N.E. Statistical Methods in Cancer Research. IARC, Lyon, 1987.
7. Carde, P., Hagenbeek, A., Hayat, M. et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organisation for Research and Treatment of Cancer Lymphoma Cooperative Group. J. Clin. Oncol. 11: 2258-2272, 1993.
8. Carlson, R.G., Mayfield, W.R., Normann, S. and Alexander, A.J. Radiation-associated valvular disease. Chest 99: 538-545, 1991.
9. Coltart, R.S., Roberts, J.T., Thom, C.H. and Petch, M.C. Severe constrictive pericarditis after single 16 MeV anterior mantle irradiation for Hodgkin's disease. Lancet 1: 488-489, 1985.
10. Constine, L.S., Schwartz, R.G., Savage, D.E., King, V., Muhs, A. and Rubin, P. Persistence of normal cardiac function in irradiated long-term survivors of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 36 (Suppl. 1): 171, 1996.
11. Corn, W.B., Trock, B.J. and Goodman, R.L. Irradiation-related ischemic heart disease. Review article. J. Clin. Oncol. 8: 741-750, 1990.
12. Cosset, J.M., Henry-Amar, M., Girinski, T., Malaise, E., Dupouy, N. and Dutreix, J. Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size. Acta Oncol. 27: 123-129, 1988.
13. Cosset, J.M., Henry-Amar, M., Pellae-Cosset, B. et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int. J. Radiat. Oncol. Biol. Phys. 21: 447-449, 1991.
14. Dai, S., Marti, B., Tschopp, A., Bodenmann, A. and Gutzwiller, F. Kardiovaskuläre Risikofaktoren von Besuchern eines Messe-Screening-Standes. Schweiz. Rundschau Med. (Praxis) 80: 874-878, 1991.
15. Farah, R., Ultman, J., Griem, M. et al. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J. Clin. Oncol. 6: 1047-1052, 1988.
16. Ficaro, E.P., Fessler, J.A., Shreve, P.D., Kritzman, B.S., Rose, P.A. and Corbetti, J.R. Simultaneous transmission/emission myocardial perfusion tomography - diagnostic accuracy of attenuation-corrected 99msestamibi single-photon emission computed tomography. Circulation 93: 463-473, 1996.
17. Frank, E. Benefits of stopping smoking. West. J. Med. 159: 83-87, 1993.
18. Glanzmann, C., Huguenin, P., Lütolf, U.M., Maire, R., Jenni, R. and Von Gumpenberg, V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother. Oncol. 30: 43-54, 1994.
19. Gomez, G.A., Park, J.J., Panahon, A. et al. Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. Cancer Treatm. Rep. 67: 1099-1103, 1983.
20. Gord, T., Kannel, W.B. and McGee, D. Death and coronary attacks in men after giving up cigarette smoking. Lancet 2: 1345-1348, 1974.
21. Gottdiener, J.S., Katin, M.J., Borer, J.S., Bacharach, S.L. and Green, M.V. Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N. Engl. J. Med. 308: 569-572, 1983.
22. Green, D.M., Gingell, R.L., Pearce, J., Panahon, A.M. and Ghoorah, J. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J. Clin. Oncol. 5: 239-245, 1987.
23. Greiser, E., Joeckel, K.H., Giersiepen, K., Maschewsky-Schneider, U. and Zachcial, M. Cardiovascular disease risk factors, CHD morbidity and mortality in the Federal Republic of Germany. Int. J. Epidemiol. 18: 118-123, 1989.
24. Gustavsson, A., Eskilsson, T., Landberg, T. et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann. Oncol. 1: 355-363, 1990.
25. Gutzwiller, F., Rickenbach, M., Barazzoni, F. and Ackermann-Liebrich, U. Regelmässige Erfassung von Herz-Kreislauf-Risiken und -Krankheiten: sinnvoll oder nicht? (Die Monica-Erfahrung). Schweiz. Med. Wochenschrift. 123 (Suppl. 48): 8-11, 1993.
26. Hancock, S.L., Donaldson, S.S. and Hoppe, R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J. Clin. Oncol. 11: 1208-1215, 1993.
27. Hancock, S.L., Tucker, M.A. and Hoppe, R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J. Am. Med. Assoc. 270: 1949-1955, 1993.
28. Hanley, J.A. and Lippman-Hand, A. If nothing goes wrong, is everything allright? J. Am. Med. Assoc. 259: 1743-1745, 1983.
29. Henry-Amar, M., Hayat, M., Meerwaldt, J.H. et al. Causes of death after therapy for Hodgkin's disease entered on EORTC protocols. Int. J. Radiat. Oncol. Biol. Phys. 19: 1155-1157, 1990.
30. Kadota, P.R., Burgert, O., Driscoll, D.J., Evans, R.G. and Gilchrist, G.S. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma. Mayo Clin. Proc. 63: 362-367, 1988.
31. Keil, U., Filipiak, B., Döring, A. et al. Monitoring trends and determinants in cardiovascular disease in Germany: results of the Monica project Augsburg 1985-1990. MMWR 41 (Suppl.): 171-179, 1992.
32. Kipfer, P.H., Hess, O.M., Gaglione, A.M. and Krayenbuehl, H.P. Exercise-induced ST-segment depression after successful PTCA: incomplete revascularization or altered coronary vascular tone? Coron. Art. Dis. 2: 595-604, 1991.
33. Krayenbuehl, H.P. and Rutishauser, W. Kap. 23: Herz (Belastungstests). In: Klinische Pathophysiologie, pp. 590-591. Editor: W. Siegenthaler. Georg Thieme, Stuttgart, 1987.
34. LaMonte, C.S., Yeh, S.D.J. and Straus, D.J. Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicine. J. Natl. Cancer Inst. 70: 439-444, 1986.
35. Lipshultz, E.S. Dexrazoxane for protection against car diotoxic effects of anthracycline in children. J. Clin. Oncol. 14: 328-331, 1969.
36. Lipshultz, L.E., Sanders, P.S., Goorin, A.M., Krisher, J.P., Sallan, S.E. and Colan, S.D. Monitoring for anthracycline toxicity. Pediatrics 93: 433-437, 1994.
37. Lund, M.B., Ihlen, H., Voss, M.R. et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiography study. Heart 75: 591-595, 1996.
38. Mangold, K. Evaluation des kardialen Risikos der Mediastinalbestrahlung bei Morbus Hodgkin anhand nicht-invasiver Diagnostik. Medizinische Dissertation. Medizinische Fakultät Universität Zürich, 1992.
39. Mauch, P., Tarbell, N.J., Silver, B. et al. Stage IA and IIA supra-diaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J. Clin. Oncol. 6: 1576-1583, 1988.
40. Morgan, G.W., Freeman, A.P., McLean, R.G., Jarvie, B.H. and Giles, R.W. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 11: 1925-1931, 1985.
41. Oberlin, O., Leverger, G., Pacquement, H. et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J. Clin. Oncol. 10: 1602-1608, 1992.
42. Pahjola-Sintonen, S., Tötterman, K.J. and Kupari, M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer 65: 2494-2496, 1990.
43. Pahjola-Sintonen, S., Tötterman, K.J., Salmo, M. and Siltanen, P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer 60: 31-37, 1987.
44. Perrault, D.J., Levy, M., Herman, J.D. et al. Echocardiographic abnormalities following cardiac radiation. J. Clin. Oncol. 3: 546-551, 1985.
45. Pierga, J.Y., Manoury, C., Valette, H. et al. Follow-up Thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 25: 871-876, 1993.
46. Rosenberg, L., Kaufman, D.W., Helmrich, S.P. and Shapiro, S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N. Engl. J. Med. 313: 1511-1514, 1985.
47. Savage, D.E., Constine, L.S., Schwartz, R.G. and Rubin, P. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 19: 721-727, 1990.
48. Steinherz, L.J., Steinherz, P.O., Tan, C.T.C., Heller, G. and Murphy, L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J. Am. Med. Assoc. 266: 1672-1677, 1991.
49. Tan, B., Bailey, D.L., Meikle, S.R., Eberl, S., Fulton, R.R. and Hutton, B.F. A scanning line source for simultaneous emission and transmission measurements in SPECT. J. Nucl. Med. 34: 1752-1760, 1993.
50. Tarbell, N.J. and Mauch, P. Thoracic irradiation in Hodgkin's disease: disease-control and long-term complications. Int. J. Radiat. Oncol. Biol. Phys. 18: 275-281, 1990.
51. Wannamathee, G. and Shaper, A.G. Body weight and mortality in middle aged British men: impact of smoking. Br. Med. J. 299: 1497-1502, 1989.